Hereditary Angiopathy with Nephropathy Aneurysms and Muscle Cramps (HANAC)

Hereditary Angiopathy with Nephropathy, Aneurysms, and Muscle Cramps (HANAC) is a rare, inherited disorder that affects small blood vessels (the “microvasculature”) in many parts of the body, especially the kidneys, brain, eyes, and skeletal muscle. Most cases are caused by pathogenic variants in the COL4A1 gene, which encodes the α1 chain of type IV collagen, a key scaffolding protein in basement membranes that support small vessels and tissue barriers. When type IV collagen is altered, capillaries and arterioles become fragile and leaky. This can lead to blood in the urine (hematuria) and other kidney problems, cerebral small-vessel disease with risk of brain hemorrhage or white-matter changes, arterial aneurysms (local dilations of arteries), retinal vascular changes, and painful muscle cramps/myopathy. The disorder is usually autosomal dominant, meaning one altered copy of the gene is enough to cause disease; severity can vary widely, even within the same family. Trauma, uncontrolled high blood pressure, and anticoagulation may increase bleeding risk in affected vessels. Early recognition matters because monitoring and prevention (for example, blood pressure control and careful decisions about blood thinners) may reduce complications.

HANAC syndrome is a rare, inherited condition that makes many small and large blood vessels unusually fragile. It mainly involves the kidneys (causing blood or protein in urine and sometimes kidney cysts), the brain’s blood vessels (including a risk of intracranial aneurysms and small-vessel disease), the eyes (retinal arterial tortuosity), and the muscles (frequent painful cramps). HANAC belongs to a family of disorders caused by changes (mutations) in the COL4A1 gene, which encodes part of type IV collagen—a key “scaffold” protein in the basement membranes that support blood vessels and many tissues. The disorder is autosomal dominant, meaning one altered copy of the gene can cause the condition. MedlinePlus+2NCBI+2

Reviews of COL4A1-related disorders and original descriptions of HANAC document the multi-system vascular phenotype, autosomal-dominant inheritance, and basement-membrane pathology. [GeneReviews: COL4A1-Related Disorders; Orphanet; Plaisier et al., N Engl J Med; Gould & Jeanne, Hum Mol Genet]

---

Other names

• HANAC syndrome (standard name)

• COL4A1-related systemic small-vessel disease (umbrella term when systemic)

• COL4A1-associated nephropathy with aneurysms and myopathy

• Hereditary angiopathy with nephropathy (shortened form seen in some reports)

• Type IV collagen (COL4A1) vasculopathy

• Familial microangiopathy due to COL4A1

• COL4A1-related brain–kidney–muscle–eye disease (descriptive)
  Evidence: Nomenclature across GeneReviews, Orphanet, and case series shows HANAC as part of the COL4A1-related disorder spectrum with overlapping terms in literature. [GeneReviews; Orphanet; Jeanne & Gould, Development]

---

Types

Although HANAC is a defined clinical entity, doctors often classify cases along the broader COL4A1-related disorder spectrum. Helpful “types” for practical understanding include:

1. Classic HANAC phenotype: Kidney involvement (hematuria ± cysts), muscle cramps/myopathy, and systemic aneurysms ± retinal arteriolar changes.

2. Brain-predominant COL4A1 disease: Cerebral small-vessel disease with leukoencephalopathy, microbleeds, or porencephaly; less kidney or muscle involvement.

3. Kidney-predominant presentations: Recurrent hematuria, thin-basement-membrane features, or proteinuria with subtle extrarenal signs.

4. Vascular-aneurysm-predominant form: Multiple arterial aneurysms (intracranial or systemic) with mild renal and muscle features.

5. Muscle-predominant form: Painful exercise-induced cramps, mild myopathy, hyperCKemia, and angiopathic changes with minimal kidney signs.

6. Eye-predominant form: Retinal arteriolar tortuosity/hemorrhages ± other ocular findings.

7. Mixed phenotypes: Overlap of the above within a family, reflecting variable expressivity.
   Evidence: Phenotypic groupings in reviews and case reports demonstrate variable organ involvement within COL4A1-related disease, of which HANAC is a canonical pattern. [GeneReviews; Orphanet; Plaisier et al., N Engl J Med; Meuwissen et al., Brain]

---

Causes

In genetics, “cause” usually means the disease-causing variant. For HANAC, COL4A1 variants are the primary cause. Below are contributors and modifiers that either constitute the cause or worsen outcomes.

1. Pathogenic COL4A1 variants (missense, especially glycine substitutions in the collagenous domain) disrupt type IV collagen assembly, weakening microvessels. [GeneReviews]

2. Defects in triple-helix formation of collagen IV cause basement-membrane fragility and leakage. [Gould & Jeanne]

3. Endoplasmic reticulum stress from misfolded collagen increases cellular injury in vascular cells. [Gould & Jeanne]

4. Abnormal perivascular matrix remodeling promotes aneurysm formation. [Orphanet]

5. Reduced tensile strength of vessel walls predisposes to microbleeds and hematuria. [Plaisier et al.]

6. Glomerular basement-membrane thinning allows red blood cells to pass into urine. [GeneReviews]

7. Capillary rarefaction in muscle contributes to cramps and exertional pain. [Orphanet]

8. White-matter microangiopathy from leaky brain vessels leads to small strokes and lesions. [GeneReviews]

9. Intracranial aneurysm susceptibility from structural weakness of arterial walls. [Plaisier et al.]

10. Hypertension as a modifier increases risk of brain and vascular bleeding. [GeneReviews]

11. Anticoagulant/antiplatelet exposure may heighten hemorrhage risk in fragile vessels (clinical caution). [GeneReviews]

12. Head trauma can precipitate intracerebral hemorrhage in vulnerable brains. [GeneReviews]

13. Intense exertion/dehydration can aggravate muscle ischemia and cramps. [Orphanet]

14. Smoking damages endothelium and accelerates aneurysm growth. [Vascular-disease guidelines; applied principle]

15. Hyperlipidemia/atherosclerosis further weakens arterial walls. [Vascular-risk literature]

16. Pregnancy and delivery-related stress can trigger hemorrhage in some COL4A1 disorders (rare but reported). [GeneReviews]

17. Migraine physiology may interact with small-vessel dysfunction (reported in some families). [Case series]

18. Infections with high fever may precipitate cramps and dehydration-related kidney stress. [General pathophysiology applied]

19. Poor blood-pressure control over time accelerates white-matter disease. [GeneReviews]

20. Age-related vascular wear superimposed on congenital fragility increases aneurysm risk. [Orphanet; general vascular data]

Core cause is COL4A1 variation; other items are well-recognized disease modifiers or pathophysiologic contributors reported in reviews/guidance for COL4A1-related vasculopathy. [GeneReviews; Orphanet; Gould & Jeanne; Plaisier et al.]

---

Symptoms

1. Blood in urine (hematuria): Often microscopic and intermittent; due to thin, fragile glomerular basement membranes. [GeneReviews]

2. Protein in urine (proteinuria): Leakage of proteins from injured glomeruli; may be mild to moderate. [Orphanet]

3. Kidney cysts or structural changes: Some individuals develop renal cysts or scarring over time. [Plaisier et al.]

4. Painful muscle cramps: Typically exercise-induced; reflect microvascular muscle ischemia and myopathy. [Orphanet]

5. Muscle stiffness or fatigue: From repeated cramps and low-grade muscle injury. [Case series]

6. Headaches or migraines: Possibly linked to small-vessel dysfunction. [GeneReviews]

7. Transient neurologic episodes: Numbness, weakness, or visual symptoms due to microbleeds or small strokes. [GeneReviews]

8. Intracerebral hemorrhage (sometimes): Ranging from microbleeds to larger hemorrhages, often after trauma or hypertension spikes. [GeneReviews]

9. Cognitive or balance issues: From chronic white-matter disease. [GeneReviews]

10. Vision changes: Retinal arteriolar tortuosity, small retinal hemorrhages, or blurred vision. [Orphanet]

11. Aneurysm-related pain or pulsations: Rarely “warning” pain before rupture in intracranial or systemic aneurysms. [Vascular literature]

12. Raynaud-like cold sensitivity: Vasospastic responses reported in some patients. [Case reports]

13. Hypertensive readings: Blood pressure can rise with kidney involvement or vascular stiffness. [General pathophysiology]

14. Fatigue and decreased exercise tolerance: Combination of muscle, brain, and vascular factors. [Orphanet]

15. Anxiety related to bleeding risk: Common psychosocial burden in heritable vasculopathies. [Hereditary vascular disease literature]

Evidence: Symptom clusters are drawn from COL4A1/HANAC case descriptions and reviews across kidney, muscle, eye, and brain involvement. [GeneReviews; Orphanet; Plaisier et al.; Meuwissen et al.]

---

Diagnostic tests

Clinicians select tests based on symptoms and family history, aiming to confirm the genetic cause, map organ involvement, and reduce preventable risks.

A) Physical examination

1. General and neurologic exam: Blood pressure, pulse, cardiac and neurologic screening detect focal deficits, weakness, coordination issues, or cognitive changes suggesting small-vessel disease. [GeneReviews]

2. Musculoskeletal exam: Looks for calf tenderness, trigger points, contractures, or exercise-induced pain consistent with cramps/myopathy. [Orphanet]

3. Ophthalmologic bedside checks: Visual acuity, color vision, and funduscopy can reveal retinal tortuosity or hemorrhages. [Orphanet]

4. Vascular exam: Palpation of pulses and bruits; although aneurysms are often silent, vascular clues guide imaging. [Vascular practice]

B) Manual/functional tests

5. Provoked cramp assessment (gentle functional testing): Controlled calf-raise or isometric maneuvers to reproduce and characterize cramps without overexertion. [Myology practice]

6. Six-minute walk test: Captures exercise tolerance and exertional cramp thresholds over time. [Rehab standards]

7. Handgrip dynamometry: Quantifies subtle weakness/fatigability that patients report subjectively. [Neuromuscular testing]

8. Bedside cognitive screens (MoCA/MMSE): White-matter disease can affect processing speed/executive function; brief screens track change. [Neurology standards]

C) Laboratory & pathological tests

9. Urinalysis with microscopy: Detects red blood cells and casts; hallmark of glomerular hematuria. [Nephrology guidelines]

10. Urine albumin-creatinine ratio (ACR) / 24-h protein: Quantifies protein leak to stage kidney involvement. [KDIGO]

11. Serum creatinine and eGFR: Measures kidney filtration. [KDIGO]

12. Creatine kinase (CK): May be mildly elevated from muscle injury/cramps. [Myology references]

13. Electrolytes (Mg, Ca, K): Rule out secondary contributors to cramps and arrhythmia risk. [General medicine]

14. Genetic testing for COL4A1 (and COL4A2 if indicated): Diagnostic cornerstone; identifies pathogenic variants and enables family testing. [GeneReviews]

15. Renal biopsy (selective): Not routine when genetics are diagnostic; if performed, shows basement-membrane abnormalities compatible with collagen IV defects. [Nephropathology literature]

D) Electrodiagnostic tests

16. Electromyography (EMG) and nerve conduction studies (NCS): Evaluate cramp potentials, myopathic changes, and exclude neuropathic causes. [Neuromuscular standards]

17. EEG (if seizures or atypical events): Not universal, but used when hemorrhage or cortical irritation is suspected. [Neurology practice]

E) Imaging tests

18. Brain MRI (including susceptibility-weighted imaging): Detects white-matter hyperintensities, microbleeds, old lacunes, or porencephaly; helps risk-stratify. [GeneReviews]

19. Intracranial MRA/CTA: Screens for aneurysms or stenoses; frequency individualized based on age and family history. [Vascular neurology guidance]

20. Renal ultrasound ± MRI: Evaluates kidney size, cysts, scarring, and blood flow without radiation. [Nephrology practice]

21. Retinal photography/OCT: Documents arteriolar tortuosity, hemorrhages, and macular changes. [Ophthalmology standards]

22. Whole-body or targeted arterial imaging (CTA/MRA): Looks for extra-cranial aneurysms (e.g., carotid, renal, visceral). [Vascular surgery guidance]

23. Echocardiography (if indicated): Assesses cardiac structure and aortic root when systemic aneurysm risk is considered. [Cardiology guidance]

24. Spinal MRI (selective): If unusual neurologic symptoms suggest spinal microangiopathy or hemorrhage. [Neurology practice]

Non-pharmacological treatments

1. Blood-pressure optimization (DASH + lifestyle)
   What: Follow the DASH eating plan, lower sodium, maintain healthy weight, stay active, limit alcohol. Why: Lower pressure reduces stress on fragile vessels and lowers aneurysm and kidney risks. How: DASH lowers BP via increased potassium/magnesium intake, reduced sodium, and overall cardiometabolic benefits. NHLBI, NIH+1

2. Smoking cessation (if applicable)
   What: Stop all nicotine/tobacco use; use counseling and approved aids. Why: Smoking increases risk of intracranial aneurysm rupture and worsens post-procedure outcomes. How: Stopping reduces inflammatory and hemodynamic damage to arterial walls over time. PMC+1

3. Regular aneurysm surveillance
   What: Periodic MRA/CTA per neurosurgical guidance. Why: Early detection allows preventive management before rupture. How: Imaging finds size/shape changes that predict risk. AHA Journals+1

4. Head-injury avoidance
   What: Use helmets, avoid high-impact sports when advised. Why: Fragile vessels increase hemorrhage risk after trauma. How: Reducing mechanical forces lowers bleed risk. NCBI

5. Careful use/avoidance of anticoagulation when possible
   What: Only use antithrombotics when benefits clearly outweigh bleeding risk. Why: Fragile vessels raise hemorrhage risk. How: Shared decision-making with neurology/nephrology. NCBI

6. Hydration & heat management for cramps
   What: Adequate fluids, electrolyte-aware hydration before exertion. Why: Dehydration/exertion can trigger cramps. How: Maintains muscle perfusion and neuromuscular excitability balance. (Cochrane finds mixed benefit for magnesium; hydration/stretching is low-risk.) Cochrane

7. Stretching program
   What: Daily calf/hamstring/foot intrinsic muscle stretches, especially before bed. Why: Reduces nocturnal leg cramps frequency and severity in many people. How: Lowers alpha-motor neuron hyperexcitability and tendon shortening. NCBI

8. Warmth and graded activity
   What: Warm showers/heat packs, graded walking/cycling. Why: Improves microvascular flow, reduces spasm. How: Vasodilation and muscle conditioning. NCBI

9. Vision monitoring
   What: Routine eye exams. Why: Retinal arterial tortuosity can bleed; early detection protects sight. How: Fundus photography/OCT. EyeWiki

10. Kidney protection steps
    What: Avoid nephrotoxins (NSAID overuse, contrast without need), manage BP, control proteinuria. Why: Preserve kidney function. How: Lifestyle, ACEi/ARB (see drug section). Kidney Foundation

11. Genetic counseling & family screening
    What: Offer testing to at-risk relatives. Why: Early identification enables surveillance and prevention. How: Autosomal-dominant inheritance education. NCBI

12. Pregnancy planning
    What: Preconception counseling with maternal-fetal medicine & neurology. Why: Manage BP and hemorrhage risks. How: Individualized surveillance plan. NCBI

13. Fall-risk reduction
    What: Home safety, balance exercises. Why: Prevent head trauma. How: PT-guided program. NCBI

14. Headache management plan
    What: Non-opioid strategies first; evaluate for secondary causes. Why: Headaches can accompany small-vessel disease/aneurysm. How: Imaging when red flags present. NCBI

15. Vaccinations (kidney disease best practice)
    What: Stay current with influenza, hepatitis B, etc., in CKD. Why: Reduce infection burden on vulnerable patients. How: Follow national CKD vaccination guidance. New England Journal of Medicine

16. Sodium reduction (<1,500–2,300 mg/day)
    What: Practical salt cuts (labels, cooking). Why: Lowers BP load on vessels. How: DASH-sodium trials show additive benefit. NHLBI, NIH

17. Exercise (aerobic + light resistance)
    What: 150 min/week moderate activity. Why: Improves BP, endothelial health. How: Increases nitric-oxide bioavailability and vascular compliance. NCBI

18. Stress & sleep management
    What: Sleep hygiene, CBT-I, mindfulness. Why: Poor sleep/stress can raise BP and cramps perception. How: Autonomic balance. NCBI

19. Limit alcohol & avoid stimulants
    What: Keep alcohol within low-risk limits; avoid cocaine/amphetamines. Why: Hypertensive surges and vasospasm. How: Reduces vascular events. NCBI

20. Shared, multidisciplinary care
    What: Coordinate nephrology, neurology/neurosurgery, ophthalmology, genetics, primary care. Why: Multisystem disease needs team oversight. How: Guideline-driven monitoring intervals. AHA Journals

---

Drug treatments

There is no disease-specific, FDA-approved drug for HANAC. Care uses standard agents to control blood pressure, reduce proteinuria, treat seizures or headaches when present, and lower overall vascular risk. Labels below are provided via accessdata.fda.gov for accurate indications, dosing ranges, and safety. Always tailor to kidney function and comorbidities, and weigh bleed risk carefully if antithrombotics are considered.

1. Enalapril (ACE inhibitor)—Start 2.5–5 mg daily; titrate to BP/proteinuria targets. Purpose: lower BP and proteinuria to protect kidneys and vessels. Mechanism: blocks angiotensin-converting enzyme → vasodilation and reduced intraglomerular pressure. Side effects: cough, hyperkalemia, renal function changes, fetal toxicity (boxed warning). FDA Access Data+1

2. Losartan (ARB)—Start 25–50 mg daily; titrate. Purpose: alternative to ACEi (cough/intolerance), reduces proteinuria and BP. Mechanism: AT1 receptor blockade. Side effects: hyperkalemia, renal function changes, fetal toxicity (boxed warning), avoid with aliskiren in diabetes. FDA Access Data

3. Amlodipine (CCB)—Start 2.5–5 mg daily. Purpose: add-on BP control if needed. Mechanism: vascular smooth-muscle calcium-channel blockade. Side effects: edema, flushing, dizziness. FDA Access Data+1

4. Labetalol (alpha/beta-blocker)—Start 100 mg twice daily. Purpose: adjunct BP control, including in pregnancy contexts under specialist care. Mechanism: alpha-1 and beta blockade. Side effects: bradycardia, fatigue; contraindications include asthma and heart block. FDA Access Data+1

5. Hydrochlorothiazide (thiazide diuretic)—12.5–25 mg daily. Purpose: add-on BP control. Mechanism: distal tubule natriuresis. Side effects: hyponatremia, hypokalemia; photosensitivity/skin cancer warning. FDA Access Data

6. Combination ACEi/diuretic (enalapril/HCTZ)—Use if fixed-dose helps adherence. Purpose: BP/proteinuria control. Mechanism: dual (RAAS + natriuresis). Warnings as per components. FDA Access Data

7. Benazepril/amlodipine (Lotrel)—Fixed-dose ACEi/CCB for tougher BP. Purpose: simplification with two mechanisms. Warnings include fetal toxicity (ACEi). FDA Access Data

8. Atorvastatin—10–40 mg nightly if dyslipidemia or vascular risk. Purpose: reduce atherosclerotic risk; indirect benefit for overall cerebrovascular health. Mechanism: HMG-CoA reductase inhibition. Side effects: myopathy/rhabdomyolysis risk, liver enzyme elevations. FDA Access Data+1

9. Levetiracetam (if seizures occur)—Start 500 mg twice daily; adjust for kidney function. Purpose: seizure control after intracranial hemorrhage or cortical irritability. Mechanism: binds SV2A to modulate neurotransmission. Side effects: somnolence, mood changes; dose adjust in CKD. FDA Access Data+1

10. Acetaminophen for pain/headache—500–1,000 mg PRN within label limits. Purpose: safer analgesic option when avoiding NSAID overuse in CKD risk. Mechanism: central COX inhibition. Side effects: hepatotoxicity with overdose; mind total daily dose. FDA Access Data

11. Amlodipine oral solution (Norliqva)—Useful when tablets unsuitable. Same mechanism and cautions as tablets. FDA Access Data

12. Losartan oral suspension (newer formulation)—Alternative for those with swallowing issues; same class effects as tablets. FDA Access Data

13. Combination amlodipine/atorvastatin (Caduet)—For concurrent hypertension + dyslipidemia; simplifies regimen. Monitor for statin adverse effects. FDA Access Data

14. IV labetalol (acute BP control in hospital settings)—For hypertensive emergencies under specialist care. FDA Access Data

15. Clopidogrel (use with caution; only if a clear indication, e.g., stent)—Given vessel fragility, antiplatelets should be carefully individualized with neurology/neurosurgery. Boxed warning on CYP2C19 poor metabolizers. FDA Access Data

16. Enalapril oral solution (Epaned)—ACE inhibitor in liquid form (same class cautions). FDA Access Data+1

17. Atorvastatin oral suspension (Atorvaliq)—Alternative formulation for dyslipidemia treatment. FDA Access Data

18. Levetiracetam extended-release—Once-daily option for seizure control adherence. FDA Access Data

19. Acetaminophen combo products—If used, ensure total acetaminophen dose stays within label limits to avoid hepatotoxicity. FDA Access Data

20. Shared rule: Maximize ACEi/ARB to tolerated target to reduce proteinuria and protect kidneys; combine thoughtfully with other BP agents to reach goals. Mayo Clinic Proceedings+1

Important safety note: Because HANAC features fragile vessels, any antiplatelet or anticoagulant needs individualized risk–benefit discussion; there is no blanket recommendation to use them in HANAC. NCBI

---

Dietary molecular supplements

1. Magnesium (food-first; supplements have mixed data for cramps): Typical supplemental doses 200–400 mg/day; UL for supplemental magnesium is 350 mg/day (GI side effects above this). Function: neuromuscular excitability; Mechanism: cofactor in ion transport and muscle relaxation. Evidence for leg-cramp prevention is inconsistent in high-quality reviews. Office of Dietary Supplements+1

2. Potassium-rich foods (within kidney-safe limits): Bananas, leafy greens, legumes. Dose: from diet as guided by CKD stage. Function: supports BP control (part of DASH). Mechanism: natriuresis/vasodilation effects. NHLBI, NIH

3. Omega-3 fatty acids (dietary fish intake): 1–2 fatty-fish meals/week. Function: general cardiometabolic risk reduction. Mechanism: anti-inflammatory, triglyceride lowering. (Adjunctive, not HANAC-specific.) NCBI

4. Vitamin D (replete if deficient): Usual 800–1,000 IU/day or per lab-guided regimen. Function: musculoskeletal health. Mechanism: calcium–phosphate balance; muscle function. Office of Dietary Supplements

5. B-complex (select cases): Some low-certainty data suggest B vitamins may help idiopathic nocturnal leg cramps in older adults. Use only if deficient or after clinician advice. NCBI

6. Coenzyme Q10 (uncertain): Antioxidant used for myalgias with statins; evidence mixed. Use cautiously if on statin. FDA Access Data

7. Citrate from foods (citrus, vegetables): May help minimize stone risk in CKD patients with stone history; not HANAC-specific. NCBI

8. Calcium (food-based): Follow RDA unless nephrology advises restriction; excessive calcium isn’t helpful. Function: neuromuscular signaling. Office of Dietary Supplements

9. Antioxidant-rich diet (berries, vegetables): Whole-diet pattern supports vascular health; mechanism via reduced oxidative stress. NHLBI, NIH

10. Caffeine moderation: Not a supplement, but limiting excess caffeine may reduce cramp triggers in some; evidence anecdotal. NCBI

Avoid “megadose” supplements and always check interactions if you have CKD. Magnesium excess can be dangerous in kidney disease. Office of Dietary Supplements

---

Immunity-booster / regenerative / stem-cell drugs

There are no FDA-approved “immunity-boosting,” regenerative, or stem-cell drugs to treat HANAC or to repair COL4A1-related vascular basement membranes. Listing such products for this condition would be misleading. Management focuses on risk-factor control, surveillance, and treating complications (e.g., BP, proteinuria, aneurysms, seizures) with standard approved medicines (see above). NCBI

---

Procedures/surgeries

1. Endovascular coiling of intracranial aneurysm—Catheter-based filling of aneurysm with coils to prevent rupture. Why: For selected aneurysms meeting size/location/morphology thresholds or showing growth/symptoms. AHA Journals

2. Microsurgical clipping of aneurysm—Open surgery to place a clip at the aneurysm neck. Why: Alternative to coiling depending on anatomy, patient age, and center expertise. AHA Journals

3. Flow-diverting stent—Endovascular device to redirect blood away from aneurysm sac. Why: Selected wide-neck or complex lesions. Mayo Clinic Proceedings

4. CSF diversion (rare situations)—Ventriculoperitoneal shunt if hydrocephalus from hemorrhage or porencephaly sequelae. Why: Manage elevated intracranial pressure. Mayo Clinic Proceedings

5. Renal procedures (uncommon)—Intervention for symptomatic large cysts (e.g., aspiration) or complications. Why: Symptom relief; otherwise conservative. New England Journal of Medicine

---

Prevention tips

1. Keep BP in target with lifestyle and medicines. NHLBI, NIH

2. Don’t smoke; if you do, quit. PMC

3. Follow imaging surveillance for aneurysms. AHA Journals

4. Avoid head injury; use helmets; reconsider high-impact sports. NCBI

5. Review antithrombotics; avoid unless clearly indicated. NCBI

6. Stay hydrated; stretch to reduce cramps. Cochrane

7. Kidney-safe habits: avoid unnecessary NSAIDs/contrast. Kidney Foundation

8. Healthy diet (DASH) and weight control. NHLBI, NIH

9. Genetic counseling for family planning. NCBI

10. Keep vaccinations current as advised in CKD/general care. New England Journal of Medicine

---

When to see a doctor (or go to the ER)

Seek urgent care for a sudden severe headache (“worst headache of life”), new neurologic deficits (weakness, speech trouble, vision loss), or after significant head trauma—these can signal aneurysm rupture or brain bleed. See your doctor promptly for new or worsening blood in urine, swelling, rising BP, vision changes, fainting/arrhythmias, or frequent painful muscle cramps not improving with stretching and hydration; you may need medication adjustments or imaging. AHA Journals+1

---

What to eat & what to avoid

Eat more: fruits, vegetables, whole grains, legumes, nuts, seeds, fish; choose low-fat dairy; cook with less salt; flavor with herbs/citrus. This mirrors DASH, which lowers BP and supports vascular health. NHLBI, NIH

Eat less/avoid: high-sodium processed foods, excess red/processed meats, sugary drinks, heavy alcohol, and excessive NSAID use without clinician advice (kidney safety). If CKD is present, ask your nephrologist about potassium and phosphorus limits before using high-potassium salt substitutes. NHLBI, NIH

---

Frequently asked questions

1. Is HANAC curable? No cure yet; care focuses on preventing bleeds, protecting kidneys, and treating symptoms. NCBI

2. Is it always severe? No—severity varies widely even in the same family. NCBI

3. Can I exercise? Yes—moderate aerobic activity is encouraged; avoid head-injury-prone sports if advised. NCBI

4. Do I need lifelong imaging? Many people need periodic brain vessel imaging; your team will set the interval. AHA Journals

5. Are ACEi/ARBs really necessary? They’re commonly used to reduce proteinuria and protect kidneys when indicated. Kidney Foundation

6. Should I take aspirin “just in case”? Not automatically—ask your specialists; bleeding risk must be weighed carefully. NCBI

7. Can magnesium stop my cramps? Evidence is mixed; stretching/hydration helps many people. Cochrane

8. Will my children have it? Each child has a 50% chance if you carry the variant; genetic counseling helps. NCBI

9. Are my eyes at risk? Retinal arteries can be tortuous and fragile; keep regular ophthalmology visits. EyeWiki

10. Can pregnancy be safe? Many do well with careful high-risk obstetric and neurology care. NCBI

11. Do statins treat HANAC? No—they treat cholesterol and reduce atherosclerotic risk. FDA Access Data

12. What about stem cells? None are approved for HANAC. Avoid unproven therapies. NCBI

13. How often should BP be checked? At home several times per week (or per clinician advice) to stay in target. NHLBI, NIH

14. Do small headaches matter? Most don’t, but “thunderclap” headaches or new neurologic signs require emergency care. AHA Journals

15. Where can I read more? Start with GeneReviews and MedlinePlus Genetics for clinician-vetted overviews. NCBI+1

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 02, 2025.